Market Access Director, Hellenic Association of Pharmaceutical Companies (SFEE)

Dr. Christos Georgakopoulos is the Market Access Director of the Hellenic Association of Pharmaceutical Companies (SFEE) since 2018, coming from Leo Pharma, where he held the position of Global Medical Director Thrombosis in Denmark.

He has 30 years of experience in academia and the pharmaceutical industry. He began his career in 1994 as a lecturer and then as assistant professor at the University of Portsmouth, UK. During his professional career in the pharmaceutical industry, he held positions of high responsibility in areas such as Medical & Scientific Affairs, Market Access, Clinical Development, Regulatory Affairs, Pharmacovigilance and Compliance in multinational pharmaceutical companies such as Abbott Laboratories, Actelion, Schering-Plough and Leo Pharma in Europe, Middle East, Africa, Latin & South America and Greece.

During his career, he gained experience in many therapeutic areas such as Oncology, Dermatology, Thrombosis, Osteoporosis, Cardiology, Rheumatology, but also experience in designing Health Policies, designing and implementing pricing and reimbursement strategies and policies, as well as designing clinical trials.

He holds a PhD in Biochemistry and a BSc in Biomedical Sciences from the University of Portsmouth, UK. He speaks English, German and Greek.